ECSP003583A - CRYSTALLINE FORM III OF N- [4- (5- DIMETILAMINONAFTALEN-1-SULFONILAMINO) FENIL] -3-HIDROXI-2,2-DIMETILPROPIONAMIDA (CASE LEA 33884-EC) - Google Patents

CRYSTALLINE FORM III OF N- [4- (5- DIMETILAMINONAFTALEN-1-SULFONILAMINO) FENIL] -3-HIDROXI-2,2-DIMETILPROPIONAMIDA (CASE LEA 33884-EC)

Info

Publication number
ECSP003583A
ECSP003583A ECSP003583A ECSP003583A EC SP003583 A ECSP003583 A EC SP003583A EC SP003583 A ECSP003583 A EC SP003583A EC SP003583 A ECSP003583 A EC SP003583A
Authority
EC
Ecuador
Prior art keywords
crystalline form
sulfonilamino
dimetilpropionamida
dimetilaminonaftalen
hidroxi
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Alfons Grunenberg
Andreas Lender
Andree Folkerts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP003583 priority Critical patent/ECSP003583A/en
Publication of ECSP003583A publication Critical patent/ECSP003583A/en

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Forma cristalina III de la N-(4-(5-dimetilaminonaftalen-1-sulfonilamino )fenil)-3-hidroxi-2,2-dimetilpropionamida (DNSP) de fórmula (gráfico).Crystalline form III of N- (4- (5-dimethylaminonaphthalen-1-sulfonylamino) phenyl) -3-hydroxy-2,2-dimethylpropionamide (DNSP) of the formula (graph).

ECSP003583 2000-07-21 2000-07-21 CRYSTALLINE FORM III OF N- [4- (5- DIMETILAMINONAFTALEN-1-SULFONILAMINO) FENIL] -3-HIDROXI-2,2-DIMETILPROPIONAMIDA (CASE LEA 33884-EC) ECSP003583A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP003583 ECSP003583A (en) 2000-07-21 2000-07-21 CRYSTALLINE FORM III OF N- [4- (5- DIMETILAMINONAFTALEN-1-SULFONILAMINO) FENIL] -3-HIDROXI-2,2-DIMETILPROPIONAMIDA (CASE LEA 33884-EC)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP003583 ECSP003583A (en) 2000-07-21 2000-07-21 CRYSTALLINE FORM III OF N- [4- (5- DIMETILAMINONAFTALEN-1-SULFONILAMINO) FENIL] -3-HIDROXI-2,2-DIMETILPROPIONAMIDA (CASE LEA 33884-EC)

Publications (1)

Publication Number Publication Date
ECSP003583A true ECSP003583A (en) 2000-08-18

Family

ID=42041195

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP003583 ECSP003583A (en) 2000-07-21 2000-07-21 CRYSTALLINE FORM III OF N- [4- (5- DIMETILAMINONAFTALEN-1-SULFONILAMINO) FENIL] -3-HIDROXI-2,2-DIMETILPROPIONAMIDA (CASE LEA 33884-EC)

Country Status (1)

Country Link
EC (1) ECSP003583A (en)

Similar Documents

Publication Publication Date Title
NO20040933L (en) Novel gamma-secretase inhibitors.
ATE308544T1 (en) N-SUBSTITUIETE HETEROARYLOXY-ARYL-SPIRO-PYRIMIDINE-2,4,6-TRION METALLOPROTEINASE INHIBITORS
NO20042885L (en) Aryloxyphenyl and arylsulfanylphenyl derivatives
CY1114284T1 (en) SULFONYL PYROLS AS HDAC SUSPENSIONS
NO20034045D0 (en) Metalloproteinases inhibitors
SE0000540D0 (en) New compounds
ATE403429T1 (en) SPIROPYRAZOLE COMPOUNDS
DE50210090D1 (en) SUBSTITUTED PHENYL DERIVATIVES
DK1542977T3 (en) 2,5-Dioxoimidazolidin-4-ylacetamides and Analogs as Inhibitors of Metalloproteinase MMP12
ATE304015T1 (en) TRIARYL-OXY-ARYL-SPIRO-PYRIMIDINE-2, 4, 6-TRION METALLOPROTEINASE INHIBITORS
NO20035245L (en) Basic Wi-Fi architecture for 802.11 networks
CY1112780T1 (en) NEW SULFONYLPYRROLIA AS HDAC SUSPENSIONS
NO20034032L (en) Metalloproteinases inhibitors
DK1524981T3 (en) Sustained-release compositions containing lamotrigine
SE0103710D0 (en) Compounds
HRP20080057T3 (en) 9,10-alpha,alpha-oh-taxane analogs and methods for production thereof
MY128164A (en) Compounds
EA200801365A1 (en) SUBSTITUTED 5-PHENYL-3,6-DIGIDRO-2-OXO-6H-1,3,4-TIADIAZINS
NO20023951L (en) Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibitors
ATE396170T1 (en) MONOAMINE INTAKE INHIBITOR
EA200600608A1 (en) IMIDAZOPIRIDINE DERIVATIVES AS INDUCED NO-SYNTHASE INHIBITORS
AR024797A1 (en) CRYSTALLINE FORM III OF THE N- (4- (5-DIMETHYLAMINONAFTALEN-1-SULPHONYLAMINE) PHENYL) -3-HYDROXI-2,2-DIMETHYLPROPIONAMIDE
NO20024679D0 (en) Crystalline Pharmaceuticals
ATE364037T1 (en) TRYPTASE INHIBITORS
AR028052A1 (en) PHENYL COMPOUNDS REPLACED INHIBITORS OF FARNESIL TRANSFERASA